{"title":"Neurological Diseases Caused by Loss of Transfer RNA Modifications: Commonalities in Their Molecular Pathogenesis.","authors":"Takeshi Chujo, Kazuhito Tomizawa","doi":"10.1016/j.jmb.2025.169047","DOIUrl":null,"url":null,"abstract":"<p><p>Human transfer RNA (tRNA) contains 46 post-transcriptional modifications at specific tRNA positions, which are incorporated by specific modifying enzymes. These tRNA modifications support the structural and biochemical stability of tRNAs and codon-anticodon interactions. Pathogenic genetic variants and disease-associated expressional aberrations have been identified in more than 50 human tRNA modification enzymes and their partner proteins. These are the causes of various diseases and disorders collectively termed 'tRNA modopathies.' Nervous tissue is the most affected tissue in the body upon loss of tRNA modifications, and 37 tRNA modification writers have pathogenic variants that cause neurological diseases. Here, we describe the molecular functions of human tRNA modifications and provide a thorough compilation of >80 human tRNA modification writers and neurological tRNA modopathies. Although largely unexplored, there is growing evidence for the pathogenic mechanisms of neurological tRNA modopathies. Loss of tRNA modifications can cause tRNA destabilization, altered decoding, or production of toxic tRNA fragments, which lead to the severely dysregulated proteostasis that causes neurodegeneration, or the mild translational defects that cause memory impairment. We present herein an overview of these mechanisms and discuss the development of therapeutic strategies and future avenues of research to determine the exact role of tRNA modifications in the nervous system.</p>","PeriodicalId":369,"journal":{"name":"Journal of Molecular Biology","volume":" ","pages":"169047"},"PeriodicalIF":4.7000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.jmb.2025.169047","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Human transfer RNA (tRNA) contains 46 post-transcriptional modifications at specific tRNA positions, which are incorporated by specific modifying enzymes. These tRNA modifications support the structural and biochemical stability of tRNAs and codon-anticodon interactions. Pathogenic genetic variants and disease-associated expressional aberrations have been identified in more than 50 human tRNA modification enzymes and their partner proteins. These are the causes of various diseases and disorders collectively termed 'tRNA modopathies.' Nervous tissue is the most affected tissue in the body upon loss of tRNA modifications, and 37 tRNA modification writers have pathogenic variants that cause neurological diseases. Here, we describe the molecular functions of human tRNA modifications and provide a thorough compilation of >80 human tRNA modification writers and neurological tRNA modopathies. Although largely unexplored, there is growing evidence for the pathogenic mechanisms of neurological tRNA modopathies. Loss of tRNA modifications can cause tRNA destabilization, altered decoding, or production of toxic tRNA fragments, which lead to the severely dysregulated proteostasis that causes neurodegeneration, or the mild translational defects that cause memory impairment. We present herein an overview of these mechanisms and discuss the development of therapeutic strategies and future avenues of research to determine the exact role of tRNA modifications in the nervous system.
期刊介绍:
Journal of Molecular Biology (JMB) provides high quality, comprehensive and broad coverage in all areas of molecular biology. The journal publishes original scientific research papers that provide mechanistic and functional insights and report a significant advance to the field. The journal encourages the submission of multidisciplinary studies that use complementary experimental and computational approaches to address challenging biological questions.
Research areas include but are not limited to: Biomolecular interactions, signaling networks, systems biology; Cell cycle, cell growth, cell differentiation; Cell death, autophagy; Cell signaling and regulation; Chemical biology; Computational biology, in combination with experimental studies; DNA replication, repair, and recombination; Development, regenerative biology, mechanistic and functional studies of stem cells; Epigenetics, chromatin structure and function; Gene expression; Membrane processes, cell surface proteins and cell-cell interactions; Methodological advances, both experimental and theoretical, including databases; Microbiology, virology, and interactions with the host or environment; Microbiota mechanistic and functional studies; Nuclear organization; Post-translational modifications, proteomics; Processing and function of biologically important macromolecules and complexes; Molecular basis of disease; RNA processing, structure and functions of non-coding RNAs, transcription; Sorting, spatiotemporal organization, trafficking; Structural biology; Synthetic biology; Translation, protein folding, chaperones, protein degradation and quality control.